Literature DB >> 16394009

Activation of TLR-9 induces IL-8 secretion through peroxynitrite signaling in human neutrophils.

Levente József1, Tarek Khreiss, Driss El Kebir, János G Filep.   

Abstract

Bacterial DNA containing unmethylated CpG motifs is emerging as an important regulator of functions of human neutrophil granulocytes (polymorphonuclear leukocytes (PMN)). These motifs are recognized by TLR-9. Recent studies indicate that peroxynitrite (ONOO-) may function as an intracellular signal for the production of IL-8, one of the key regulators of leukocyte trafficking in inflammation. In this study we investigated whether bacterial DNA (CpG-DNA) could induce ONOO- signaling in human PMN. Human whole blood, isolated PMN (purity, >95%), and high purity (>99%) PMN respond to CpG-DNA, but not to calf thymus DNA, with secretion of IL-8 and, to a lesser extent, IL-6 and TNF. Methylation of cytosines in CpG-DNA resulted in a complete loss of activity. The endosomal acidification inhibitors, bafilomycin A and chloroquine, inhibited CpG-DNA-induced cytokine release from PMN. CpG-DNA-induced IL-8 mRNA expression and release was also blocked by the NO synthase inhibitor Nomega-nitro-L-arginine methyl ester. CpG-DNA evoked concomitant increases in intracellular superoxide and NO levels, leading to enhanced ONOO- formation and, consequently, nuclear accumulation of c-Fos and NF-kappaB. Pharmacological inhibition of NF-kappaB activation attenuated approximately 75% of CpG-DNA-evoked IL-8 release. These results identify ONOO- -dependent activation of NF-kappaB and c-Fos as an important mechanism that mediates PMN responses, including IL-8 gene expression and release, to bacterial DNA and unmethylated CpG motifs in particular. Enhanced ONOO- formation represents a mechanism by which bacterial DNA may contribute to prolongation and amplification of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394009     DOI: 10.4049/jimmunol.176.2.1195

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  The genome sequence of Atlantic cod reveals a unique immune system.

Authors:  Bastiaan Star; Alexander J Nederbragt; Sissel Jentoft; Unni Grimholt; Martin Malmstrøm; Tone F Gregers; Trine B Rounge; Jonas Paulsen; Monica H Solbakken; Animesh Sharma; Ola F Wetten; Anders Lanzén; Roger Winer; James Knight; Jan-Hinnerk Vogel; Bronwen Aken; Oivind Andersen; Karin Lagesen; Ave Tooming-Klunderud; Rolf B Edvardsen; Kirubakaran G Tina; Mari Espelund; Chirag Nepal; Christopher Previti; Bård Ove Karlsen; Truls Moum; Morten Skage; Paul R Berg; Tor Gjøen; Heiner Kuhl; Jim Thorsen; Ketil Malde; Richard Reinhardt; Lei Du; Steinar D Johansen; Steve Searle; Sigbjørn Lien; Frank Nilsen; Inge Jonassen; Stig W Omholt; Nils Chr Stenseth; Kjetill S Jakobsen
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

2.  HIV-1-neutrophil interactions trigger neutrophil activation and Toll-like receptor expression.

Authors:  Diana Marcela Giraldo; Juan Carlos Hernandez; Paula Velilla; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

3.  TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes.

Authors:  Jessica E Thaxton; Roberto Romero; Surendra Sharma
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

4.  Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase.

Authors:  Sybille Kenzel; Miriam Mergen; Julius von Süßkind-Schwendi; Julia Wennekamp; Sachin D Deshmukh; Monika Haeffner; Antigoni Triantafyllopoulou; Sebastian Fuchs; Susan Farmand; Sandra Santos-Sierra; Jochen Seufert; Timo K van den Berg; Taco W Kuijpers; Philipp Henneke
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

5.  Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.

Authors:  Peter K Henke; Mayo Mitsuya; Catherine E Luke; Megan A Elfline; Joseph F Baldwin; K Barry Deatrick; Jose A Diaz; Vikram Sood; Gilbert R Upchurch; Thomas W Wakefield; Cory Hogaboam; Steven L Kunkel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-21       Impact factor: 8.311

Review 6.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

7.  HIV-1-derived single-stranded RNA acts as activator of human neutrophils.

Authors:  Diana M Giraldo; Juan C Hernandez; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

Review 8.  Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.

Authors:  Mark P Simons; William M Nauseef; Thomas S Griffith
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Assessment of bovine mammary chemokine gene expression in response to lipopolysaccharide, lipotechoic acid + peptidoglycan, and CpG oligodeoxynucleotide 2135.

Authors:  Jeremy A Mount; Niel A Karrow; Jeff L Caswell; Herman J Boermans; Ken E Leslie
Journal:  Can J Vet Res       Date:  2009-01       Impact factor: 1.310

10.  CpG-containing immunostimulatory DNA sequences elicit TNF-alpha-dependent toxicity in rodents but not in humans.

Authors:  John D Campbell; Yan Cho; Martyn L Foster; Holger Kanzler; Melissa A Kachura; Jeremy A Lum; Marianne J Ratcliffe; Atul Sathe; Andrew J Leishman; Ash Bahl; Mark McHale; Robert L Coffman; Edith M Hessel
Journal:  J Clin Invest       Date:  2009-08-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.